International Normalized Ratio
"International Normalized Ratio" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
System established by the World Health Organization and the International Committee on Thrombosis and Hemostasis for monitoring and reporting blood coagulation tests. Under this system, results are standardized using the International Sensitivity Index for the particular test reagent/instrument combination used.
| Descriptor ID |
D019934
|
| MeSH Number(s) |
E01.370.225.625.115.320 E05.200.625.115.320
|
| Concept/Terms |
International Normalized Ratio- International Normalized Ratio
- International Normalized Ratios
- Normalized Ratio, International
- Normalized Ratios, International
- Ratio, International Normalized
- Ratios, International Normalized
- INR
|
Below are MeSH descriptors whose meaning is more general than "International Normalized Ratio".
Below are MeSH descriptors whose meaning is more specific than "International Normalized Ratio".
This graph shows the total number of publications written about "International Normalized Ratio" by people in this website by year, and whether "International Normalized Ratio" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 4 | 25 | 29 |
| 2018 | 6 | 28 | 34 |
| 2019 | 3 | 5 | 8 |
| 2020 | 0 | 6 | 6 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "International Normalized Ratio" by people in Profiles.
-
Drive-through point-of-care INR testing: Novel concepts for delivery of care during the COVID-19 pandemic. Am J Health Syst Pharm. 2022 01 01; 79(1):e4-e7.
-
Evaluation of the "safe multidisciplinary app-assisted remote patient-self-testing (SMART) model" for warfarin home management during the COVID-19 pandemic: study protocol of a multi-center randomized controlled trial. BMC Health Serv Res. 2021 Aug 26; 21(1):875.
-
The short-term effect of the COVID-19 pandemic on the management of warfarin therapy. Kardiologiia. 2021 Jul 31; 61(7):55-59.
-
INR and COVID-19 severity and mortality: A systematic review with meta-analysis and meta-regression. Adv Med Sci. 2021 Sep; 66(2):372-380.
-
Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil. Thromb Res. 2021 09; 205:81-83.
-
Side-Effects of COVID-19 on Patient Care: An INR Story. J Appl Lab Med. 2021 07 07; 6(4):953-961.
-
Blood coagulation parameter abnormalities in hospitalized patients with confirmed COVID-19 in Ethiopia. PLoS One. 2021; 16(6):e0252939.
-
The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease. Int Immunopharmacol. 2021 Sep; 98:107838.
-
Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population. Sensors (Basel). 2021 Apr 09; 21(8).
-
Outpatient management of chronic warfarin therapy at a pharmacist-run anticoagulation clinic during the COVID-19 pandemic. J Thromb Thrombolysis. 2021 Oct; 52(3):754-758.